Get conference updates straight to your inbox.
Expert Interviews
In this video, Dr. Garcia-Manero discusses the study's primary endpoint, its implications for patients, and more.
The “real revolution” in myeloma is in the immune therapies, Dr. Anderson said, such as bispecific T-cell engagers and ...
Meeting News
2024 Conference Coverage
The American Association for Cancer Research (AACR) Annual Meeting 2024 took place April 5-10 in San Diego, California.
The 2024 ASPHO Conference featured education and networking events for advanced practice providers.
The 2024 Tandem Meetings featured the latest in hematopoietic stem cell transplantation and cellular therapy.
ASH 2023 Conference Coverage
This section of the 2023 ASH Annual Meeting focused on the latest developments on myelodysplastic syndromes.
This section of the 2023 ASH Annual Meeting focused on the latest developments on multiple myeloma.
This section of the 2023 ASH Annual Meeting focused on the latest developments on leukemia.
This section of the 2023 ASH Annual Meeting focused on the latest developments in MPN with a focus in myelofibrosis.
This section of the 2023 ASH Annual Meeting focused on the latest developments on myeloproliferative neoplasms.
These highlights from the 65th ASH Annual Meeting and Exposition focused on the most recent updates in lymphoma care.
This section of the 2023 ASH Annual Meeting focused on the latest developments in hematologic malignancies.
Eleventh SOHO Annual Meeting Coverage
The Eleventh Society of Hematologic Oncology Annual Meeting focused on the latest advances in the field.
This section of news from Eleventh SOHO Annual Meeting focused on the latest developments in MDS.
This section of meeting news focused on research updates and new developments in leukemia.
Advertisement
2023 Conference Coverage
Blood Cancers Today covers updates in hematologic malignancies at JADPRO Live 2023, including myeloma news.
The latest in clinical trials, analysis of the impact of driver mutations in MPNs, and more.
The 38th SITC Annual Meeting covered topics on blood cancers and immunotherapies.
The 20th International Myeloma Society Annual Meeting and Exposition was held September 27-30 in Athens, Greece.
The 2023 SNMMI Annual Meeting took place from June 24 to June 27 in Chicago.
The European Hematology Association (EHA) 2023 Congress was held June 8-11, 2023, in Frankfurt, Germany.
The American Association for Cancer Research (AACR) Annual Meeting 2023 took place April 14-19 in Orlando, Florida.
The EHA-EBMT Fifth European CAR T-Cell Meeting was held February 9-11 in Rotterdam, Netherlands.
The AACR Special Conference: Acute Myeloid Leukemia and Myelodysplastic Syndrome took place from January 23-25, 2023.
2023 ASCO Annual Meeting Coverage
The 2023 American Society of Clinical Oncology (ASCO) Annual Meeting took place June 2 through June 6 in Chicago, Illinois.
This section of news from the 2023 ASCO Annual Meeting focused on the latest developments in MPN from the meeting.
This section of the 2023 ASCO Annual Meeting focused on the latest developments in multiple myeloma from the meeting.
This section of news from the 2023 ASCO Annual Meeting focused on the latest developments in lymphoma from the meeting,
This section of news from the 2023 ASCO Annual Meeting focused on the latest developments in leukemia from the meeting.
2022 Conference Coverage
The 2022 SITC Annual Meeting was held November 8-12 and covered topics on blood cancers and immunotherapies.
The latest in clinical trials, transcriptional profiling of extracellular matrix-related genes in MPNs, and more
The 2022 ESMO Congress, held September 9-13 in Paris, France, featured a range of topics on hematologic malignancies.
The 19th Annual International Myeloma Society (IMS) Meeting took place from August 25-27, 2022.
Coverage of the ASCO 2022 meeting
EHA 2022 Congress coverage
Tenth SOHO Annual Meeting Coverage
We focused on updates presented on myelodysplastic syndromes (MDS) at the 2022 SOHO Annual Meeting.
The 10th Annual Meeting of the Society of Hematologic Oncology was held from September 28–October 1, 2022.
ASH 2022 Conference Coverage
This section of the 2022 ASH Annual Meeting focused on the latest developments in multiple myeloma from the meeting.
This section focused on the latest news in leukemia from ASH 2022.
This section of the 2022 ASH Annual Meeting focused on the latest developments in lymphoma from the meeting.
This section of the 2022 ASH Annual Meeting focused on the latest developments in myelodysplastic syndromes from the meeting.
This section of the 2022 ASH Annual Meeting focused on the latest news in myeloproliferative neoplasms from the meeting.
This section of the 2022 ASH Annual Meeting focused on the latest developments in hematologic malignancies.
2021 Conference Coverage
2021 ASH Annual Meeting coverage
Research, education, and insight from the 2021 SOHO Annual Meeting
At SOHO 2021, Susan O'Brien, MD, and Hagop Kantarjian, MD, addressed trends in hematologic malignancies.
Multiple myeloma was featured as a highlight of the Late-Breaking Abstracts session.
Blood Cancers Today delivers the latest news, education, and information relevant to hematologic oncology patients and practices.
Sign up to receive Blood Cancers Today eNewsletters:
Knowledge Hubs
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
Meeting News
2024 Conference Coverage
The American Association for Cancer Research (AACR) Annual Meeting 2024 took place April 5-10 in San Diego, California.
The 2024 ASPHO Conference featured education and networking events for advanced practice providers.
The 2024 Tandem Meetings featured the latest in hematopoietic stem cell transplantation and cellular therapy.
Advertisement
ASH 2023 Conference Coverage
This section of the 2023 ASH Annual Meeting focused on the latest developments on myelodysplastic syndromes.
This section of the 2023 ASH Annual Meeting focused on the latest developments on multiple myeloma.
This section of the 2023 ASH Annual Meeting focused on the latest developments on leukemia.
This section of the 2023 ASH Annual Meeting focused on the latest developments in MPN with a focus in myelofibrosis.
This section of the 2023 ASH Annual Meeting focused on the latest developments on myeloproliferative neoplasms.
These highlights from the 65th ASH Annual Meeting and Exposition focused on the most recent updates in lymphoma care.
This section of the 2023 ASH Annual Meeting focused on the latest developments in hematologic malignancies.
Advertisement
Eleventh SOHO Annual Meeting Coverage
The Eleventh Society of Hematologic Oncology Annual Meeting focused on the latest advances in the field.
This section of news from Eleventh SOHO Annual Meeting focused on the latest developments in MDS.
This section of meeting news focused on research updates and new developments in leukemia.
2023 Conference Coverage
Blood Cancers Today covers updates in hematologic malignancies at JADPRO Live 2023, including myeloma news.
The latest in clinical trials, analysis of the impact of driver mutations in MPNs, and more.
The 38th SITC Annual Meeting covered topics on blood cancers and immunotherapies.
The 20th International Myeloma Society Annual Meeting and Exposition was held September 27-30 in Athens, Greece.
The 2023 SNMMI Annual Meeting took place from June 24 to June 27 in Chicago.
The European Hematology Association (EHA) 2023 Congress was held June 8-11, 2023, in Frankfurt, Germany.
The American Association for Cancer Research (AACR) Annual Meeting 2023 took place April 14-19 in Orlando, Florida.
The EHA-EBMT Fifth European CAR T-Cell Meeting was held February 9-11 in Rotterdam, Netherlands.
The AACR Special Conference: Acute Myeloid Leukemia and Myelodysplastic Syndrome took place from January 23-25, 2023.
2023 ASCO Annual Meeting Coverage
The 2023 American Society of Clinical Oncology (ASCO) Annual Meeting took place June 2 through June 6 in Chicago, Illinois.
This section of news from the 2023 ASCO Annual Meeting focused on the latest developments in MPN from the meeting.
This section of the 2023 ASCO Annual Meeting focused on the latest developments in multiple myeloma from the meeting.
This section of news from the 2023 ASCO Annual Meeting focused on the latest developments in lymphoma from the meeting,
This section of news from the 2023 ASCO Annual Meeting focused on the latest developments in leukemia from the meeting.
2022 Conference Coverage
The 2022 SITC Annual Meeting was held November 8-12 and covered topics on blood cancers and immunotherapies.
The latest in clinical trials, transcriptional profiling of extracellular matrix-related genes in MPNs, and more
The 2022 ESMO Congress, held September 9-13 in Paris, France, featured a range of topics on hematologic malignancies.
The 19th Annual International Myeloma Society (IMS) Meeting took place from August 25-27, 2022.
Coverage of the ASCO 2022 meeting
EHA 2022 Congress coverage
Tenth SOHO Annual Meeting Coverage
We focused on updates presented on myelodysplastic syndromes (MDS) at the 2022 SOHO Annual Meeting.
The 10th Annual Meeting of the Society of Hematologic Oncology was held from September 28–October 1, 2022.
ASH 2022 Conference Coverage
This section of the 2022 ASH Annual Meeting focused on the latest developments in multiple myeloma from the meeting.
This section focused on the latest news in leukemia from ASH 2022.
This section of the 2022 ASH Annual Meeting focused on the latest developments in lymphoma from the meeting.
This section of the 2022 ASH Annual Meeting focused on the latest developments in myelodysplastic syndromes from the meeting.
This section of the 2022 ASH Annual Meeting focused on the latest news in myeloproliferative neoplasms from the meeting.
This section of the 2022 ASH Annual Meeting focused on the latest developments in hematologic malignancies.
2021 Conference Coverage
2021 ASH Annual Meeting coverage
Research, education, and insight from the 2021 SOHO Annual Meeting
At SOHO 2021, Susan O'Brien, MD, and Hagop Kantarjian, MD, addressed trends in hematologic malignancies.
Multiple myeloma was featured as a highlight of the Late-Breaking Abstracts session.
Blood Cancers Today delivers the latest news, education, and information relevant to hematologic oncology patients and practices.
Sign up to receive Blood Cancers Today eNewsletters:
Knowledge Hubs
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
Get conference updates straight to your inbox.
Expert Interviews
In this video, Dr. Garcia-Manero discusses the study's primary endpoint, its implications for patients, and more.
The “real revolution” in myeloma is in the immune therapies, Dr. Anderson said, such as bispecific T-cell engagers and ...
